We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$1.22B
AUM Growth
+$236M
Cap. Flow
+$242M
Cap. Flow %
19.95%
Top 10 Hldgs %
10.08%
Holding
636
New
201
Increased
78
Reduced
62
Closed
295

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.2M
2
DVN icon
Devon Energy
DVN
+$12.8M
3
ULTA icon
Ulta Beauty
ULTA
+$12.7M
4
GS icon
Goldman Sachs
GS
+$12.7M
5
MNST icon
Monster Beverage
MNST
+$11.6M

Top Sells

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$10.6M
2
LUV icon
Southwest Airlines
LUV
+$10.2M
3
XOM icon
ExxonMobil
XOM
+$10.2M
4
COST icon
Costco
COST
+$9.96M
5
PPL
PPL Corp
PPL
+$9.81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.31%
2 Technology 17.79%
3 Financials 12.54%
4 Healthcare 11.75%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
251
CVS Health
CVS
$133B
$693K 0.06%
11,143
-31,400
-74% -$2.25M
AVY icon
252
Avery Dennison
AVY
$13B
$685K 0.06%
+6,448
New +$747K
ENR icon
253
Energizer
ENR
$1.44B
$684K 0.06%
+11,478
New +$619K
CAVM
254
DELISTED
Cavium, Inc.
CAVM
$655K 0.05%
8,250
-34,000
-80% -$2.97M
EFX icon
255
Equifax
EFX
$20.3B
$636K 0.05%
+5,400
New +$648K
CFG icon
256
Citizens Financial Group
CFG
$30.3B
$626K 0.05%
+14,902
New +$669K
TLRD
257
DELISTED
Tailored Brands, Inc.
TLRD
$624K 0.05%
24,900
-60,400
-71% -$1.4M
BGS icon
258
B&G Foods
BGS
$287M
$599K 0.05%
+25,283
New +$774K
NSC icon
259
Norfolk Southern
NSC
$75.4B
$584K 0.05%
4,300
+800
+23% +$115K
IFF icon
260
International Flavors & Fragrances
IFF
$20.2B
$581K 0.05%
+4,246
New +$615K
TROW icon
261
T. Rowe Price
TROW
$23.9B
$572K 0.05%
+5,300
New +$590K
VFC icon
262
VF Corp
VFC
$5.63B
$568K 0.05%
+8,132
New +$588K
EQT icon
263
EQT Corp
EQT
$33.3B
$562K 0.05%
21,735
-34,903
-62% -$1M
BG icon
264
Bunge Global
BG
$20.4B
$550K 0.05%
7,435
-53,100
-88% -$4.01M
AAPL icon
265
Apple
AAPL
$4.54T
$537K 0.04%
12,800
-89,600
-88% -$3.86M
MRK icon
266
Merck
MRK
$322B
$506K 0.04%
9,728
+1,258
+15% +$67.9K
MRVL icon
267
Marvell Technology
MRVL
$168B
$506K 0.04%
24,074
-356,900
-94% -$8.17M
CLVS
268
DELISTED
Clovis Oncology, Inc.
CLVS
$491K 0.04%
+9,306
New +$543K
FSLR icon
269
First Solar
FSLR
$22.7B
$489K 0.04%
6,893
-24,200
-78% -$1.65M
UNFI icon
270
United Natural Foods
UNFI
$3.08B
$474K 0.04%
11,038
-8,562
-44% -$387K
TRU icon
271
TransUnion
TRU
$15.1B
$471K 0.04%
+8,300
New +$479K
BP icon
272
BP
BP
$116B
$466K 0.04%
12,374
-12,530
-50% -$472K
HUM icon
273
Humana
HUM
$43.7B
$457K 0.04%
1,700
-5,000
-75% -$1.35M
PE
274
DELISTED
PARSLEY ENERGY INC
PE
$457K 0.04%
15,754
-15,746
-50% -$419K
QLYS icon
275
Qualys
QLYS
$5.1B
$451K 0.04%
+6,200
New +$428K
9 10
11
12 13

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Seven Eight Capital held 636 positions worth $1.22B, up 24% from $979M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Seven Eight Capital deployed $242M of net new capital in Q1 2018, opening 201 new positions and adding to 78 existing holdings. Its largest new stake was AbbVie: 129,358 shares worth $12.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Nutanix, an estimated $10.6M trimmed.

  • Seven Eight Capital's largest Q1 2018 buy was AbbVie: 129,358 shares worth $12.2M.
  • Seven Eight Capital added most to Ulta Beauty in Q1 2018, an estimated $12.7M increase.
  • Seven Eight Capital's biggest Q1 2018 reduction was Nutanix, cutting an estimated $10.6M.
  • Seven Eight Capital fully exited Southwest Airlines in Q1 2018, selling an estimated $10.2M.
  • Seven Eight Capital's ten largest holdings make up 10% of its $1.22B portfolio in Q1 2018.
  • Seven Eight Capital opened 201 new positions and closed 295 in Q1 2018.
  • Seven Eight Capital's portfolio value rose 24% quarter-over-quarter to $1.22B.

Based on Seven Eight Capital's 13F filing for Q1 2018, filed 14 May 2018.